Tuesday, 18 June 2019

Drug Discovery News

  • Phyto-pharmaceuticals to hit Indian markets soon

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Dec, 2013

    Singapore: The Indian Ministry of Health and Family Welfare has notified the draft rules on a new domain of medicines called phyto-pharmaceuticals, amending the country's Drug and Cosmetic ...Read more

  • Novartis' thalassemia drug Exjade get EMA nod

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

    Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Novartis' Exjade (deferasirox). The drug is u...Read more

  • FDA scraps advisory committee on Merck's drug

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

    Singapore: The US FDA has cancelled an advisory committee meeting that was scheduled to be held on July 18, 2013, in order to discuss Merck & Co's drug Sugammadex. The drug is designed ...Read more

  • Patrys cancer drug gives hope to patients

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 May, 2013

    Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has demonstrated the mechanism by which it occurs in patients with multipl...Read more

  • Agilent, SomaLogic to expand proteomic tech

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2013

    Singapore: Agilent Technologies and US-based SomaLogic have entered into an agreement to expand access to SomaLogic's unbiased protein biomarker discovery platform. The companies will initi...Read more

  • Boehringer and Lilly get FDA nod for add-on insulin drug

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 20 Aug, 2012

    Singapore: Boehringer Ingelheim and Eli Lilly and Company received approved from the US FDA for a supplemental new drug application (sNDA) for Tradjenta (linagliptin) tablets for use as add...Read more

  • Regeneron, Sanofi brain drug has side effects: US FDA

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2014

    Singapore: Regeneron Pharmaceuticals and Sanofi have been asked by the US FDA to assess potential neurocognitive side effects of their experimental cholesterol drug. Amgen also highlighted ...Read more

  • TWi gets US patent for type II diabetes drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Sep, 2013

    Singapore: Taiwan-based TWi Biotechnology has received notification of patent allowance for AC-201, its lead drug candidate, from the US Patent and Trademark Office.The granted patent, US p...Read more

  • Nose cancer emerges as a potent killer in Asia

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2013

    Singapore: Nasopharyngeal carcinoma (NPC) is a rare form of cancer in Western Europe and North America and is emerging as a leading cancer in Southern China and South East Asia, according t...Read more

  • Elsevier: Prana drug among 'Top 10 CNS Projects'

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

    Singapore: A clinical drug for Huntington's and Alzheimer's disease by Australia-based Prana Biotechnology, a global developer of first-in-class treatments for neurodegenerative disease, ha...Read more

  • Pharma sales is getting strong'

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Aug, 2015

    Singapore: Despite concerns around declines in R&D, there would be a surge in global sales in the coming years reaching upto $1.3 trillion by 2018, according to Intellectual Property an...Read more

  • Taiwan to get its first biosafety level 3 plant

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: Amaran Biotechnology is going to invest $33.41 million (NT$1 billion) in order to construct a plant and a research center at Hsinchu Biomedical Science Park in Hsinchu County, Ta...Read more

  • Drawbridge initiates clinical trial for anaesthetic drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Dec, 2013

    Singapore: Australia-based Drawbridge Pharmaceuticals has commenced a phase 1C clinical trial of alphaxalone dissolved in sulfobutyl ether beta cyclodextrin, Phaxan. The project is a random...Read more

  • Clinuvel gets positive results in Scenesse trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its US phase IIa pilot study (CUV102) of the novel drug Scenesse (afamelan...Read more

  • Rectal cancer drug can be used to treat diabetes

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2013

    Singapore: A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway, a series of interaction among proteins, involved in the develop...Read more

  • BioPharma Asia: Dr Deborah Rathjen wins Life Science Woman Executive of the Year award

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 17 Mar, 2014

    Singapore: Dr Deborah Rathjen, CEO of Australia based Bionomics, was awarded the Life Science Woman Executive of the Year award for her contribution to both the biopharma industry and socie...Read more

  • Researchers find new link to study brain tumor

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jun, 2012

    Singapore: A joint study by researchers at the National Neuroscience Institute (NNI), National University of Singapore (NUS), and Singapore Institute for Clinical Sciences (SICS), A*STAR, h...Read more

  • BioDiem BDM-1 gets Chinese divisional patent

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Feb, 2013

    Singapore: BioDiem received a grant of a Chinese divisional patent, expanding the patent position for its novel antimicrobial compound BDM-I. The parent patent was granted in China during 2...Read more

Podcast

 

Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls